Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2013

Feb 27, 2013

30071_dirs_2013-02-27_d11bd797-a860-4df3-9178-a9ae20ee287b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2012-11-21

Reporting Person: Reiser Anne (President - ResMed Europe)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-11-21 ResMed Common Stock M 10286 $40.72 Acquired 30863.705 Direct
2012-11-21 ResMed Common Stock M 5429 $40.72 Acquired 36292.705 Direct
2012-12-31 ResMed Common Stock J 237 $40.72 Disposed 36055.705 Direct
2012-12-31 ResMed Common Stock J 125 $40.72 Disposed 36803.142 Direct

Footnotes

F1: Represents acceleration of RSUs granted on 12/17/2009 to correct a clerical error and qualify for preferential tax treatment.

F2: Represents acceleration of RSUs granted on 11/11/2010 to correct a clerical error and qualify for preferential tax treatment.

F3: Represents a cancellation of the 11/21/2012 vesting in order to apply correct tax rate which resulted in disposition to issuer for tax withholding upon vesting of Performance-based Restricted Stock Units granted on December 17, 2009.

F4: Represents a cancellation of the 11/21/2012 vesting in order to apply correct tax rate which resulted in disposition to issuer for tax withholding upon vesting of Performance-based Restricted Stock Units granted on November 10, 2010.

F5: Includes 765.796 shares of stock purchased on 4/30/2012 pursuant to ResMed's Employee Purchase Plan. Also includes 106.637 shares purchased on October 31, 2012, through ResMed's Employee Stock Purchase Plan.